Keith W Jarosinski1, John E Carpenter2, Erin M Buckingham2, Wallen Jackson2, Kevin Knudtson3, Jennifer F Moffat4, Hirohito Kita5, Charles Grose2. 1. Department of Microbiology, University of Iowa, Iowa City, Iowa. 2. Division of Infectious Diseases/Virology, University of Iowa, Iowa City, Iowa. 3. Iowa Institute of Human Genetics, University of Iowa, Iowa City, Iowa. 4. Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York. 5. Department of Immunology, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: The infectious cycle of varicella-zoster virus (VZV) after reactivation from the dorsal root ganglia includes replication and assembly of complete enveloped virions in the human skin to cause the characteristic herpes zoster (shingles). METHODS: To pursue studies of innate immunity to VZV infection, we have adapted a fetal skin organ culture model to a human neonatal foreskin explant model. RESULTS: Abundant expression of VZV IE62, gE, and gC was visualized by confocal microscopy while numerous enveloped virions were observed by electron microscopy in infected skin organ cultures. Microarray experiments demonstrated that the patterns of upregulated transcripts differed between VZV-infected cells and VZV-infected skin explants. One result stood out, namely a >30-fold elevated interleukin (IL)-6 level in the infected skin explant that was not present in the infected monolayer culture. The IL-6 results in the polyermase chain reaction (PCR) assay were reproduced by quantitative PCR testing with newly designed primers. To determine if increased transcription was accompanied by increased IL-6 expression, we quantitated the levels of IL-6 protein in the explant media at increasing intervals after infection. We found a statistically significant increase in IL-6 protein levels secreted into the media from VZV-infected skin explants as compared with mock-infected explants. CONCLUSIONS: The cellular stress response to VZV infection in neonatal skin explants included highly elevated levels of IL-6 transcription and expression. This skin organ model could be adapted to other viruses with a skin tropism, such as herpes simplex virus.
BACKGROUND: The infectious cycle of varicella-zoster virus (VZV) after reactivation from the dorsal root ganglia includes replication and assembly of complete enveloped virions in the human skin to cause the characteristic herpes zoster (shingles). METHODS: To pursue studies of innate immunity to VZV infection, we have adapted a fetal skin organ culture model to a human neonatal foreskin explant model. RESULTS: Abundant expression of VZV IE62, gE, and gC was visualized by confocal microscopy while numerous enveloped virions were observed by electron microscopy in infected skin organ cultures. Microarray experiments demonstrated that the patterns of upregulated transcripts differed between VZV-infected cells and VZV-infected skin explants. One result stood out, namely a >30-fold elevated interleukin (IL)-6 level in the infected skin explant that was not present in the infected monolayer culture. The IL-6 results in the polyermase chain reaction (PCR) assay were reproduced by quantitative PCR testing with newly designed primers. To determine if increased transcription was accompanied by increased IL-6 expression, we quantitated the levels of IL-6 protein in the explant media at increasing intervals after infection. We found a statistically significant increase in IL-6 protein levels secreted into the media from VZV-infected skin explants as compared with mock-infected explants. CONCLUSIONS: The cellular stress response to VZV infection in neonatal skin explants included highly elevated levels of IL-6 transcription and expression. This skin organ model could be adapted to other viruses with a skin tropism, such as herpes simplex virus.
Entities:
Keywords:
autophagy; cytokines; herpes virus; human skin; tocilizumab
Authors: Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi Journal: Nat Rev Dis Primers Date: 2015-07-02 Impact factor: 52.329
Authors: B Karsten Tischer; Benedikt B Kaufer; Marvin Sommer; Felix Wussow; Ann M Arvin; Nikolaus Osterrieder Journal: J Virol Date: 2007-10-03 Impact factor: 5.103
Authors: Ahmad Bayat; Peter D Burbelo; Sarah K Browne; Mark Quinlivan; Bianca Martinez; Steven M Holland; Asokumar Buvanendran; Jeffrey S Kroin; Andrew J Mannes; Judith Breuer; Jeffrey I Cohen; Michael J Iadarola Journal: J Transl Med Date: 2015-10-20 Impact factor: 5.531
Authors: Christy S Niemeyer; Teresa Mescher; Andrew N Bubak; Eva M Medina; James E Hassell; Maria A Nagel Journal: Viruses Date: 2022-03-25 Impact factor: 5.818
Authors: Prashanth S Ramachandran; Michael R Wilson; Gaud Catho; Geraldine Blanchard-Rohner; Nicoline Schiess; Randall J Cohrs; David Boutolleau; Sonia Burrel; Tetsushi Yoshikawa; Anne Wapniarski; Ethan H Heusel; John E Carpenter; Wallen Jackson; Bradley A Ford; Charles Grose Journal: Viruses Date: 2021-11-16 Impact factor: 5.048